St. Chaptes, United Kingdom

Anthony R Rees

This inventor holds 1 USPTO granted patent. Top assignee: Neorx Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony R Rees. Retrieved from https://idiyas.com/inventor/anthony-r-rees-pastn7ah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anthony R Rees

Introduction

Anthony R Rees is a notable inventor based in St. Chaptes, Great Britain. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work has implications for both therapeutic and diagnostic applications.

Latest Patents

Anthony R Rees holds a patent for "Humanized antibodies that bind to the antigen bound by antibody NR-LU-13." This patent describes humanized antibodies that specifically bind to the NR-LU-13 antigen. It also covers conjugates containing such antibodies and their use in pretargeting methods, conventional antibody therapy, and immunodiagnosis.

Career Highlights

Rees is associated with Neorx Corporation, where he continues to advance his research and development efforts. His work at Neorx Corporation focuses on innovative solutions in the field of antibody therapies.

Collaborations

Throughout his career, Anthony R Rees has collaborated with notable colleagues, including Scott Stoll Graves and John M Reno. These collaborations have further enhanced the impact of his research in the biotechnology sector.

Conclusion

Anthony R Rees is a distinguished inventor whose work on humanized antibodies has the potential to transform therapeutic and diagnostic practices. His contributions to the field are invaluable and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…